VanEck Associates
INSP icon

VanEck Associates’s Inspire Medical Systems INSP Stock Holding History

VanEck Associates’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Buy
5,267
+1,025
+24% +$48.6K ﹤0.01% 1289
2026
Q1 		$219K Buy
4,242
+2,228
+111% +$156K ﹤0.01% 1256
2025
Q4 		$186K Sell
2,014
-12
-0.6% -$1.15K ﹤0.01% 1290
2025
Q3 		$150K Buy
2,026
+736
+57% +$74.5K ﹤0.01% 1301
2025
Q2 		$167K Buy
1,290
+87
+7% +$12.6K ﹤0.01% 1267
2025
Q1 		$192K Buy
1,203
+90
+8% +$16.3K ﹤0.01% 1236
2024
Q4 		$206K Buy
1,113
+384
+53% +$74.5K ﹤0.01% 1226
2024
Q3 		$140K Sell
729
-300
-29% -$52.1K ﹤0.01% 1223
2024
Q2 		$138K Buy
1,029
+72
+8% +$13.6K ﹤0.01% 1226
2024
Q1 		$206K Sell
957
-39
-4% -$7.64K ﹤0.01% 1173
2023
Q4 		$203K Buy
996
+143
+17% +$23.2K ﹤0.01% 1167
2023
Q3 		$169K Buy
853
+178
+26% +$44.9K ﹤0.01% 1174
2023
Q2 		$219K Sell
675
-66
-9% -$18.9K ﹤0.01% 1164
2023
Q1 		$173K Sell
741
-5
-0.7% -$1.26K ﹤0.01% 1185
2022
Q4 		$188K Buy
+746
New +$159K ﹤0.01% 1113

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VanEck Associates's INSP Position: Q2 2026 in Review

VanEck Associates increased its Inspire Medical Systems (INSP) stake by 24% in Q2 2026, buying an estimated $48.6K and bringing the position to 5,267 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

VanEck Associates first reported a position in INSP in Q4 2022 and has held it in 15 quarters since. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • VanEck Associates held 5,267 shares of Inspire Medical Systems worth $235K as of Q2 2026.
  • VanEck Associates bought 1,025 Inspire Medical Systems shares in Q2 2026, an estimated $48.6K.
  • Inspire Medical Systems made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1289 holding.
  • VanEck Associates first reported a position in Inspire Medical Systems in Q4 2022 and has held it in 15 quarters since.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.